Gene Query: TMEM30A

Dataset Description Geneva Score
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 96.65
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 96.65
EP400 is required for Max and MCPyV mediated gene activation 52.2
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 50.85
IMP3 regulated gene expression in breast cancer cells 47.89
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 44.48
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 36.79
CD73 knockdown effect in pancreatic cancer cell lines 33.07
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 32.25
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 31.53
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 29.36
Uridylation by TUT4 and TUT7 marks mRNA for degradation 29.0
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 27.04
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 26.11
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 25.1
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 24.61
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 24.47
Expression data from miR340 overexpressing human A549 cells 24.39
Cleavage Factor Im as a key regulator of 3’ UTR length 24.03
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 24.01
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 23.54
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 23.12
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 23.0
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 22.57
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 22.45
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 22.36
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 22.31
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 21.74
Survival of pancreatic cancer cells lacking KRAS function 21.31
Ribosomal footprinting of MDA-Parental and MDA-LM2 21.14
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 20.53
Ribosomal footprinting of CN34-Parental and CN34-LM1a 20.28
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 19.96
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 19.94
Genome wide expression change by RNF168 knocking down in MCF-7 cells 19.83
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 19.5
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 19.49
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 19.48
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 19.29
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 19.24
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 19.09
Differential expression of genes in AD169-infected MRC5. 18.94
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 18.89
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 18.89
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 18.68
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 18.45
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 18.45
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 18.1
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 17.91
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 17.66
Sensing self and nonself circular RNAs 17.61
Regulation of highly expressed hCINAP on translatome 17.4
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 17.08
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 16.86
KSDM1b Role in Ewing Sarcoma 16.34
Genome wide expression change in LCC2 and MCF-7 cells 16.32
Gene expression regulated by CSA and CSB in neuroblastoma cell line 16.26
Identification of the role of polydom in neurofibromas 15.92
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 15.89
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 15.82
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 15.8
Differetially expressed genes after hTR overexpression in U2OS cells 15.66
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 15.64
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 15.59
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 15.48
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 15.13
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 14.91
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 14.91
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 14.77
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 14.74
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 14.71
The human blood-nerve barrier transcriptome 14.68
Solid phase chemistry to covalently and reversibly capture thiolated RNA 14.67
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 14.57
The cohesin complex prevents Myc-induced replication stress 14.42
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 14.38
Seletive inhibition of CDK9 in DLBCL cell lines 14.27
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 14.2
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 14.2
circRNA-sequencing 14.15
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 14.02
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 13.84
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 13.81
Global analyses of the effect of different cellular contexts on microRNA targeting 13.81
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 13.75
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 13.6
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.6
Human cell line and subcutaneous tumor 13.54
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 13.48
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 13.34
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 13.33
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 13.29
Global expression profiles in cardiac progenitor cells generated by ISX-9 13.28
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 13.28
Functional role of SLIT2 and ROBO1 in trophoblasts 13.22
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 13.21
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 13.08
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 13.08
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 13.07
Genome-wide functional assessment of enhancer activities in the human genome 13.06
RNA-seq melanoma 12.97
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.94
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 12.81
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 12.8
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.74
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 12.73
BET bromodomain inhibition 12.73
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 12.73
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 12.64
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 12.57
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 12.57
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 12.46
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 12.41
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 12.33
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 12.22
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.21
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 12.15
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.15
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.15
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.15
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 12.07
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 12.07
JAK dependent survival of ALK- ALCL 12.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 12.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 12.05
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 12.05
Reassessment of Exosome Composition 12.03
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 11.99
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 11.92
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 11.9
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 11.84
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 11.81
HNF1A deficiency impairs β-cell fate, granule maturation and function 11.74
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 11.73
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 11.71
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 11.69
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 11.68
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 11.68
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 11.65
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 11.65
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.63
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 11.62
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 11.49
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 11.49
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 11.44
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 11.41
Illumina Total RNA-seq in HeLa 11.33
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 11.27
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 11.27
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 11.27
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 11.1
Transcriptome analysis of BAP1 knockout and restoration 11.1
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.06
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.06
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 11.01
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 10.96
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 10.89
Aortic Valve Tissue: Stenosis vs. Sclerosis 10.88
Nutritional control of protein translation 10.87
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 10.82
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.81
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 10.77
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 10.76
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 10.76
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 10.75
Chromatin-informed inference of transcriptional programs in gynecologic cancers 10.75
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 10.75
Genome wide expression change by RNF168 knocking down in NEC cells 10.7
Mitochondrial dsRNA triggers antiviral signalling in humans 10.69
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.69
RNAseq of HEK293 cells after Chtop knockdown 10.68
Co-transcriptional loading of RNA export factors shapes the human transcriptome 10.68
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 10.62
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 10.62
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 10.62
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 10.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 10.59
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 10.58
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 10.58
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 10.57
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 10.54
Effect of PRDM11 depletion in U2932 cells 10.54
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 10.53
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 10.49
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 10.49
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 10.46
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 10.45
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.44
Identification of Atrial Fibrillation associated genes and functional non-coding variants 10.43
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 10.38
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 10.36
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 10.36
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 10.35
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.31
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 10.29
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 10.29
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 10.28
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 10.24
Differentially expressed genes post knock down of lincDUSP26 10.14
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 10.12
NR2F2 study 10.12
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.06
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 10.05
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.03
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.01
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 9.99
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 9.98
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 9.98
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.92
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.89
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 9.85
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 9.78
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 9.74
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 9.61
Effect of disulfiram treatment on pediatric high grade glioma 9.58
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 9.52
TT-Seq captures the human transient transcriptome 9.49
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 9.49
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 9.48
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 9.47
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.46
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 9.46
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 9.39
Exploring the RNA landscape of endothelial exosomes 9.34
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 9.33
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 9.23
Noncoding regions are the main source of targetable tumor-specific antigens 9.21
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 9.03
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 9.03
The transcriptome effect of overexpressing EZH2 in MCF7 8.9
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.86
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.84
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 8.83
Active translatome profiling with RiboLace in MCF7 cells 8.79
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 8.78
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 8.75
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 8.75
Effect of PBK knockdown on C4-2 cell transcriptome 8.71
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 8.68
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 8.67
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 8.63
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 8.63
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 8.63
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 8.61
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 8.61
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.6
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 8.6
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 8.59
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 8.59
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 8.39
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.24
Genome-wide identification of cancer-specific alternative splicing in circRNA 8.15
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 8.12
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 8.12
Global Mapping of Human RNA-RNA Interactions 8.11
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 8.1
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 8.1
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 8.07
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 8.07
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.99
Effect of ILF3 on translation during homeostasis and the antiviral response 7.96
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.94
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 7.84
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 7.84
Transciptomic profiling of human fetal lung samples 7.76
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.75
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.73
RNAseq of cell lines with knocked in ESR1 mutations 7.68
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 7.66
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.61
RNA-seq of RKO cells with cTAZ KO or putback 7.55
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.55
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 7.43
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 7.43
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.32
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 7.25
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 7.22
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 7.22
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 7.22
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 7.21
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 7.21
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 7.19
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 7.18
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 7.16
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 7.15
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.11
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 7.08
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 6.9
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 6.88
Transcriptome landscape of HeLa response upon triamcinolone acetonide 6.79
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 6.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 6.76
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.72
RNAseq in Alzheimer's Disease patients 6.64
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  6.62
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 6.57
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 6.54
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 6.49
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 6.47
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.46
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 6.42
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.32
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.31
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.27
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 6.24
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.22
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.17
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.11
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.11
Molecular Criteria for Defining the Naive Human Pluripotent State 6.07
Interaction between mitoNEET and NAF-1 in cancer cells 6.02
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.95
RNA-seq of naive and primed ES cells 5.93
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 5.89
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.86
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.78
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.6
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.6
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 5.53
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.44
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.42
SLIGRL-induced gene expression changes in NHEK cells 5.31
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.2
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 5.11
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 5.03
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.96
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.86
MicroRNA targetome analysis during HCMV infection 4.86
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.84
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.82
Ribosomal protein RPL26 is the principal target of UFMylation 4.8
K562 polyA RNA-Seq 4.72
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 4.66
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.62
Transcriptomic profile of human embryonic renal corpuscles 4.59
The Genetic Landscape of Diamond-Blackfan Anemia 4.46
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.39
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 4.38
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.36
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.36
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.35
mRNA expression in human DAOY cells 4.34
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.25
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.23
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.22
O-glcnAc reprograms cellular energetics 4.22
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.09
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 4.07
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 4.07
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.05
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.04
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.0
RNA Sequencing of Human iPS derived Cardiomyocytes 3.98
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.89
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.88
The contribution of Alu exons to the human proteome 3.86
Determination of tRNA aminoacylation levels by high throughput sequencing 3.86
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.83
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.77
MicroRNA-125a-5p overexpression in human macrophages 3.74
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.74
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.74
RNA seq_PDX2_SHP099 3.68
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.68
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.64
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.58
Measure transcript integrity using RNA-seq data 3.5
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.5
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.43
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.41
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.3
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 3.22
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.2
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.12
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.06
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.04
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.04
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.96
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.88
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.87
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.84
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.65
RNA-Seq of PRMT1 overexpression ECA109 cells 2.65
Aging-associated patterns in the expression of human endogenous retroviruses 2.64
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.59
Regulatory network controlling tumor-promoting inflammation in human cancers 2.57
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.57
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.52
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.5
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.48
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 2.47
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 2.47
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.41
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.38
Copper Regulation of HIF-1 Transcription Activity 2.38
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.38
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.36
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.23
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.21
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.17
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.06
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.06
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.96
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.96
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.96
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.95
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.94
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.88
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.8
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.79
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.79
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.77
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.75
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.74
naive T cell heterogeneity after neonatal thymectomy 1.74
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.72
Transcription elongation regulates genome 3D structure 1.64
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.61
Oncogenic roles of ARID5B in T-ALL 1.6
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.6
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.59
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.59
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 1.58
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.58
mRNA recovered upon RNF219 IP. [RNA-IP] 1.49
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.48
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.47
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.47
Exploring ILF2 regulatory genes by next-generation sequencing 1.43
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.37
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.35
Splicing and epigenetic factors jointly regulate epidermal differentiation 1.34
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.32
Identification of global XBP1s target gene expression in human prostate cancer cells 1.31
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.3
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.28
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.26
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.21
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.18
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.17
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.1
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.09
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.08
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.08
Transcriptome-wide response to synthetic chromatin protein PcTF 1.05
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.98
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.97
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.92
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.9
Gene expression alterations of pancreatic intraepithlial neoplasia 0.86
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.85
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.84
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.83
Modulation of nonsense-mediated decay by rapamycin 0.7
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.66
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.66
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.64
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.64
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.62
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.59
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.57
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.56
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.55
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.51
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.5
HBEC-shp53-PCHD7 0.5
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.48
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.48
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.46
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.46
Exogenous rescue of KLHL9 in SF210 cell line 0.45
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.44
Triple vectors expand AAV transfer capacity in the retina 0.44
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.43
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.43
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.43
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.41
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.36
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.35
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.33
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.33
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.25
The role of CFTR in islet function 0.24
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.23
Dilated cardiomyopathy vs Myocarditis 0.23
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.23
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.21
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.18
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.15
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.1
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.08
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.08
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.05
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.05
N6-methyladenine DNA Modification in Glioblastoma 0.05
Preclinical model of obesity and ER-positive breast cancer 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation